↓ Skip to main content

Immune-mediated hepatitis induced by immune checkpoint inhibitors: Current updates and future perspectives

Overview of attention for article published in Frontiers in Pharmacology, January 2023
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

twitter
2 X users

Readers on

mendeley
22 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Immune-mediated hepatitis induced by immune checkpoint inhibitors: Current updates and future perspectives
Published in
Frontiers in Pharmacology, January 2023
DOI 10.3389/fphar.2022.1077468
Pubmed ID
Authors

Zherui Liu, Yun Zhu, Huan Xie, Zhengsheng Zou

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 22 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 2 9%
Researcher 2 9%
Other 1 5%
Student > Ph. D. Student 1 5%
Student > Bachelor 1 5%
Other 2 9%
Unknown 13 59%
Readers by discipline Count As %
Medicine and Dentistry 5 23%
Immunology and Microbiology 2 9%
Biochemistry, Genetics and Molecular Biology 1 5%
Unknown 14 64%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 January 2023.
All research outputs
#20,491,954
of 26,051,341 outputs
Outputs from Frontiers in Pharmacology
#8,617
of 20,092 outputs
Outputs of similar age
#340,237
of 482,860 outputs
Outputs of similar age from Frontiers in Pharmacology
#337
of 938 outputs
Altmetric has tracked 26,051,341 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 20,092 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 482,860 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 938 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.